Abbott has received a CE mark for a dual glucose-ketone sensor and has declared a dividend, its 410th consecutive quarterly payout. The company's shares have shown weakness despite recent milestones, but some outlets suggest the stock may be undervalued. Abbott's stock has seen some upward movement, surging at one point and breaking above a key support level.